23302028
Results 1 to 1 of 1
Selection :
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosisVAN DEN ELSKAMP, I. J; BODEN, B; POLMAN, C. H et al.Neuroradiology (Berlin. Print). 2010, Vol 52, Num 10, pp 875-881, issn 0028-3940, 7 p.Article